Nuo Therapeutics, Inc. (AURX) bonds
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Nuo Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Nuo Therapeutics's 10-Q for the period ended May 31, 2026
| Issue | Coupon | Amount issued |
|---|---|---|
| Initial Notes | 10.00% | – |
| Interim Notes | 12.00% | – |
| Loan Agreement With Four Lenders | 10.00% | $500.00K |
| Loan Agreement With The Initial Lenders | – | $675.00K |
| The2019 Senior Secured Notes | 12.00% | $305.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| The2018 Convertible Notes | $205.00K |
See a number that looks wrong?